Cannabis Law Report

JANUARY 28, 2020

The different approaches on the legality of cultivation and use of (medical) cannabis in the member states have led to a policy paradox within the European Union, causing complications for patients in several member states. Our professionals are available to provide any tailor-made advice at short notice.

Medicine 59

Medicine Cultivation Research and Development Policy 59

Cannabis Law Report

JULY 12, 2019

As reported in the Guardian, Analytical Cannabis emphasises the importance of this for those suffering from conditions such as chronic pain, epilepsy and neurological and psychiatric disorders who have long been seeking access to what they hope is a transformative medicine. Background to the legalisation of medical cannabis in the UK.

Epilepsy 40

Epilepsy Medicine Clinical Trials Chronic Pain 40

Cannabis Law Report

AUGUST 16, 2019

Enrollment has increased from 15,000 to nearly 50,000 patients since Murphy took office. New York’s medical marijuana program has approximately 102,000 patients. The Keystone State currently has nearly 116,000 patients certified for participation in its medical marijuana program. New York Decriminalization Bill Signed Into Law.

Legalization 45

Legalization Programs Decriminalization Chronic Pain 45

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Patients can legally access medicinal cannabis through a doctor, via the TGA’s Authorised Prescribers and Special Access schemes.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

FEBRUARY 23, 2019

Mr O’Brien also runs the longest running dispensary in the world: The Patients Care Collective in Berkely. He opened the doors on April 4, 2001, and, remarkably, was never raided. What made the Patients Care Collective different? “We We were patient-focused,” he said. Our little dispensary was never targeted.

Cultivation 40

Cultivation Patients Compliance Compliance 40

Cannabis Law Report

OCTOBER 20, 2019

It is also the first FDA approved drug for the treatment of patients with Dravet syndrome. Big Pharma companies want botanical marijuana to remain illegal because it is financially beneficial to them, not because synthetic marijuana is decidedly better for patients.” as a Schedule II substance. marijuana companies.

Marijuana 45

Marijuana Pharmaceutical Chronic Pain Research and Development 45

Cannabis Law Report

SEPTEMBER 19, 2019

Medicinal cannabis was technically legalised at the start of November 2018 following several high-profile cases about children with severe forms of epilepsy being unable to access potentially life-changing cannabis-based treatment. The firm was founded in 1998 and listed on AIM in 2001 before it left London to join the NASDAQ in 2013.?Over

Pharmaceutical 40

Pharmaceutical Research and Development Medicine Oil 40

Cannabis Law Report

OCTOBER 17, 2019

Some of the potential health benefits associated with THC and CBD, with and without the high, respectively, include reducing chronic pain such as from migraines or cancer, alleviating anxiety, reducing inflammation, and helping treat conditions such as epilepsy, PTSD, and glaucoma. This is true even if the CBD comes from industrial hemp.

Law 40

Law Seed-To-Sale Hemp Recreational 40